[1] Robinson C, Collins MT, Boyce AM. Fibrous dysplasia/McCune-Albright syndrome: Clinical and translational perspectives [J]. Curr Osteoporos Rep, 2016, 14(5): 178-186.
[2] Saloustros E, Liu S, Mertz EL, et al. Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects [J]. Mol Cell Endocrinol, 2017, 439: 165-174.
[3] Kim HY, Shim JH, Heo CY. A rare skeletal disorder, fibrous dysplasia: A review of its pathogenesis and therapeutic prospects [J]. Int J Mol Sci, 2023, 24(21): 1-26.
[4] Mangion J, Edkins S, Goss AN, et al. Familial craniofacial fibrous dysplasia: absence of linkage to GNAS1 and the gene for cherubism [J]. J Med Genet, 2000, 37(11): 37-39.
[5] Hohenegger M, Waldhoer M, Beindl W, et al. Gsalpha-selective G protein antagonists [J]. Proc Natl Acad Sci U S A, 1998, 95(1): 346-351.
[6] Saggio I. Perils and promises of therapeutic approaches for the stem cell disease fibrous dysplasia [J]. Stem Cells Transl Med, 2019, 8(2): 110-111.
[7] Roszko KL, Guthrie L, Li X, et al. Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia/McCune Albright syndrome [J]. J Bone Miner Res, 2023, 38(3): 443-450.
[8] 张永栋,杨蓉, 傅瑜,等.颌骨骨纤维异常增殖症和骨化纤维瘤的临床及病理特征分析[J].口腔医学,2013,33(5): 289-293.
[9] Shi RR, Li XF, Zhang R, et al. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw [J]. Mod Pathol, 2013, 26(8): 1023-1031.
[10] Xue J, Jia K, Li T, et al. GNAS mutation analysis assists in differentiating chronic diffuse sclerosing osteomyelitis from fibrous dysplasia in the jaw [J]. Mod Pathol, 2022, 35(10): 1334-1340.
[11] Ma M, Liu L, Shi R, et al. Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws [J]. Int J Oral Sci, 2021, 13(1): 21-31.
[12] 杨柳青,陈晓红.假性甲状旁腺功能减退症遗传学研究进展[J].标记免疫分析与临床,2023,30(4): 703-708. |
